Home › Prostaatkanker › Minnesota › Minneapolis
Prostaatkanker klinische studies in Minneapolis, MN
23 studies voor Prostaatkanker zoeken deelnemers op locaties in en rond Minneapolis (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mijl verwijderd
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mijl verwijderd
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruterenFase 2
- Hennepin County Medical Center, Minneapolis
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
RekruterenFase 1
- University Of Minnesota, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
RekruterenFase 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruterenFase 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · 5 mijl verwijderd
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RekruterenFase 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RekruterenFase 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruterenFase 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · 5 mijl verwijderd
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruterenFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mijl verwijderd
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Minneapolis VA Medical Center, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
RekruterenFase 1/2
- Research Site, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RekruterenFase 2
- Masonic Cancer Center, Minneapolis
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruterenFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- en nog 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekruterenFase 1
- University of Minnesota Medical Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekruterenFase 1
- Minnesota Oncology Hematology, Minneapolis
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
RekruterenFase 1
- University of Minnesota, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
RekruterenFase 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mijl verwijderd
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekruterenFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- en nog 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Allina Health Cancer Institute, Minneapolis
Vitamin D for Prostate Endocrine Therapy
RekruterenFase 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mijl verwijderd
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruterenFase 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mijl verwijderd
Prostaatkanker studies in andere steden
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Andere studies in Minneapolis
- Borstkanker27 studies
- Niet-kleincellige longkanker26 studies
- Eierstokkanker24 studies
- Kanker (alle vormen)22 studies
- Hartfalen21 studies
- Longkanker20 studies
- Acute myeloïde leukemie20 studies
- Colorectale kanker19 studies
- Endometriumkanker18 studies
- Ziekte van Parkinson17 studies
- Cardiovasculaire ziekte15 studies
- Coronary hartziekte13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.